The Pain and Opioids in Treatment study: Characteristics of a cohort using opioids to manage chronic non-cancer pain

Pain

Volumn 156, Issue 2, 2015, Pages 231-242

  Campbell, Gabrielle ^a   Nielsen, Suzanne ^a,b   Bruno, Raimondo ^a,c   Lintzeris, Nicholas ^b,d   Cohen, Milton ^e   Hall, Wayne ^f   Larance, Briony ^a   Mattick, Richard P ^a   Degenhardt, Louisa ^a,g,h,i  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h ROYAL CHILDREN'S HOSPITAL   (Australia)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Characteristics; Chronic non cancer pain; Opioids

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BUPRENORPHINE; CODEINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; NEUROLEPTIC AGENT; OPIATE; OXYCODONE; PARACETAMOL; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANALGESIA; ARTICLE; BEHAVIOR DISORDER; CHRONIC NON CANCER PAIN; CHRONIC PAIN; CONSTIPATION; COPING BEHAVIOR; DEPRESSION; DISEASE DURATION; DROWSINESS; EMPLOYMENT; EMPLOYMENT STATUS; FATIGUE; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RETIREMENT; SUBSTANCE USE; SUICIDE; COHORT ANALYSIS; MIDDLE AGED; NEOPLASM; PHARMACY; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; CHRONIC PAIN; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN MANAGEMENT; PHARMACIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84926476291     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/01.j.pain.0000460303.63948.8e     Document Type: Article

References (55)

1. Andrews G, Hall W, Teesson M, Henderson S. The mental health of Australians: national survey of mental health and wellbeing. Canberra: Commonwealth Department of Health and Aged Care, 1999.
2. Australian Bureau of Statistics. 2071.0-Reflecting a nation: stories from the 2011 census, 2012-2013. Canberra: Australian Bureau of Statistics, 2013.
3. Australian Medicines Handbook. Australian Medicines Handbook Pty Ltd. Adelaide: 2013.
4. Belcher J, Nielsen S, Campbell G, Bruno R, Hoban B, Larance B, Lintzeris N, Degenhardt L. Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample. Drug Alcohol Rev 2014;33:27-32.
5. Blyth FM, March LM, Brnabic AJ, Jorm LR, Williamson M, Cousins MJ. Chronic pain in Australia: a prevalence study. PAIN 2001;89:127-34.
6. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287.
7. Breivik H, Eisenberg E, O'Brien T. The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health 2013;13:1229.
8. Campbell G, Mattick R, Bruno R, Larance B, Nielsen S, Cohen M, Lintzeris N, Shand F, Hall W, Hoban B, Kehler C, Farrell M, Degenhardt L. Cohort protocol: the pain and opioids in treatment (POINT) study. BMC pharmacology and toxicology 2014;15:17.
9. Centre for Disease Control and Prevention. Overview of Implementation Protocols for Testing the Washington Group Short Set of Questions on Disability. In: Washington Group on Disability Statistics (WG). Washington DC: Centre for Disease Control and Prevention, 2006.
10. Chou R. 2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain. What are the key messages for clinical practice? Pol Arch Med Wewn 2009;119:469-77.
11. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30.e122.
12. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-38.
13. Corran TM, Farrell MJ, Helme RD, Gibson SJ. The classification of patients with chronic pain: age as a contributing factor. Clin J Pain 1997; 13:207-14.
14. Coughlan GM, Ridout KL, Williams AC, Richardson PH. Attrition from a pain management programme. Br J Clin Psychol 1995;34:471-9.
15. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998;51:253-63.
16. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. PAIN 2005;113:9-19.
17. Economics A. The high price of pain: the economic impact of persistent pain in Australia. MBF Foundation, Pain Management Research Institute, University of Sydney, Sydney, Australia. 2007.
18. Faculty of Pain Medicine ANZCA. Opioid conversion to oral morphine equivalent daily dose (oMEDD). 2014.
19. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain 2012;13:715-24.
20. Glajchen M. Chronic pain: treatment barriers and strategies for clinical practice. J Am Board Fam Pract 2001;14:211-8.
21. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013;309:657-9.
22. Spritzer KL, Hays RD. MOS sleep scale: a manual for use and scoring, version 1.0. Los Angeles: 2003. Available at: http://www.rand.org/health/surveys-tools/mos/mos-sleep.html. Accessed February 4, 2014.
23. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
24. Kroenke K, Spitzer RL, Williams JBW, Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 2010;32:345-59.
25. Larance B, Bruno R, Black E, Mattick RP, Lintzeris N, Dunlop A, Cohen M, Degenhardt L. Development of the opioid related behaviours in treatment (ORBIT) scale. PAIN. In preparation.
26. Leong M, Murnion B, Haber PS. Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 2009;39:676-81.
27. Molton IR, Terrill AL. Overview of persistent pain in older adults. Am Psychol 2014;69:197.
28. Nicholas MK. The pain self-efficacy questionnaire: taking pain into account. Eur J Pain 2007;11:153-63.
29. Nicholas MK, Asghari A, Blyth FM. What do the numbers mean? Normative data in chronic pain measures. PAIN 2008;134:158-73.
30. Nielsen S, Degenhardt L, Hoban B, Gisev N. Comparing opioids: a guide to estimating oral morphine equivalents (OME) in research. NDARC Technical Report No. 329: National Drug and Alcohol Research Centre, UNSW Australia, 2014.
31. Nielsen S, Lintzeris N, Bruno R, Campbell G, Larance B, Hall W, Hoban B, Cohen M, Degenhardt L. Benzodiazepine use amongst chronic pain patients prescribed opioids: associations with pain, physical and mental health and health service utilization. Pain Med. In press.
32. Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, Chou R. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med 2014;160:38-47.
33. Passik SD, Kirsh KL, Whitcomb L, Portenoy RK, Katz NP, Kleinman L, Dodd SL, Schein JR. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 2004;26:552-61.
34. Plosker GL, Lyseng-Williamson KA. Buprenorphine 5, 10 and 20 mug/h transdermal patch: a guide to its use in chronic non-malignant pain. CNS drugs 2012;26:367-73.
35. Prins A, Ouimette P, Kimerling R, Camerond RP, Hugelshofer DS, Shaw-Hegwer J, Thrailkill A, Gusman FD, Sheikh JI. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Prim Care Psychiatry 2004;9:9-14.
36. Rogers KD, Kemp A, McLachlan AJ, Blyth F. Adverse selection? A multidimensional profile of people dispensed opioid analgesics for persistent non-cancer pain. PLoS ONE 2013;8:e80095.
37. Rowbotham MC. Pharmacologic management of complex regional pain syndrome. The Clin J Pain 2006;22:425-9.
38. Rustoen T, Wahl AK, Hanestad BR, Lerdal A, Paul S, Miaskowski C. Age and the experience of chronic pain: differences in health and quality of life among younger, middle-aged, and older adults. Clin J Pain 2005;21: 513-23.
39. Saastamoinen P, Leino-Arjas P, Laaksonen M, Lahelma E. Socio-economic differences in the prevalence of acute, chronic and disabling chronic pain among ageing employees. PAIN 2005;114:364-71.
40. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33; quiz 34-57.
41. Sherbourne CD, Stewart A. The MOS social support survey. Social Science & Medicine 1991;32:705-14.
42. Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004;13:299-310.
43. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-7.
44. Tepper SJ. Opioids Should Not Be Used in Migraine. Headache 2012;52: 30-4.
45. Terrill AL, Molton IR, Ehde DM, Amtmann D, Bombardier CH, Smith AE, Jensen MP. Resilience, age, and perceived symptoms in persons with long-term physical disabilities. J Health Psychol 2014. doi: 1359105314532973.
46. Therapeutic Goods Administration. Standard for the uniform scheduling of medicines and poisons (SUSMP). Australian Government Department of Health and Ageing, 2013. Available at: http://www.tga.gov.au/industry/scheduling-poisons-standardhtm. Accessed May 9, 2013.
47. Therapeutic Guidelines Limited. eTG complete: analgesic guidelines, Vol. 2013. Melbourne: Limited TG, 2013.
48. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J. Core outcome domainsfor chronic pain clinical trials: IMMPACT recommendations. PAIN 2003;106:337-45.
49. Turk DC, Okifuji A, Scharff L. Chronic pain and depression: role of perceived impact and perceived control in different age cohorts. PAIN 1995;61:93-101.
50. Vandenbroek P. Labour Stats 101 labour force: a quick guide. Canberra: P Library-Parliament of Australia, 2013.
51. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous SA, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha V, Bryan-Hancock C, Bucello C, Buchbinder V, Buckle GR, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen HL, Cheng ATA, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fevre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FGR, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma JX, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KMV, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leon FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJC, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JRA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang MR, Wang WZ, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SRM, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AKM, Zheng ZJ, Zonies D, Lopez AD, Murray CJL. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.
52. Wittink HM, Rogers WH, Lipman AG, McCarberg BH, Ashburn MA, Oderda GM, Carr DB. Older and younger adults in pain management programs in the United States: differences and similarities. Pain Med 2006;7:151-63.
53. Wolff RF, Reid K, di Nisio M, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R, Kleijnen J. Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain. Pain Manag 2012;2: 351-62.
54. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization, 1998.
55. World Health Organization. Composite International Diagnostic Interview, Version 3.0. Geneva: World Health Organization, 2001.